Clavulanic Acid Methyl Ester | CAS# 57943-82-5 | β-lactamase inhibitor

MedKoo Cat#: 574633 | Name: Clavulanic Acid Methyl Ester

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Clavulanic Acid Methyl Ester is a substituted Clavulanic acid and β-lactamase inhibitor.

Chemical Structure

Clavulanic Acid Methyl Ester

CAS#57943-82-5

Theoretical Analysis

MedKoo Cat#: 574633

Name: Clavulanic Acid Methyl Ester

CAS#: 57943-82-5

Chemical Formula: C9H11NO5

Exact Mass: 213.0637

Molecular Weight: 213.19

Elemental Analysis: C, 50.71; H, 5.20; N, 6.57; O, 37.52

Price and Availability

Size	Price	Availability	Quantity

Bulk Inquiry

Buy Now

Add to Cart

Related CAS #

No Data

Synonym

Clavulanic Acid Methyl Ester; Methyl Clavulanate

IUPAC/Chemical Name

(2R,3Z,5R)-3-(2-Hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid Methyl Ester

InChi Key

HTABQNQMGKGBDT-NDFJAXRBSA-N

InChi Code

InChI=1S/C9H11NO5/c1-14-9(13)8-5(2-3-11)15-7-4-6(12)10(7)8/h2,7-8,11H,3-4H2,1H3/b5-2-/t7-,8-/m1/s1

SMILES Code

O=C([C@@H](/C(O[C@]1([H])C2)=C/CO)N1C2=O)OC

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 213.19 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Keij FM, Kornelisse RF, Hartwig NG, van der Sluijs-Bens J, van Beek RHT, van Driel A, van Rooij LGM, van Dalen-Vink I, Driessen GJA, Kenter S, von Lindern JS, Eijkemans M, Stam-Stigter GM, Qi H, van den Berg MM, Baartmans MGA, van der Meer-Kappelle LH, Meijssen CB, Norbruis OF, Heidema J, van Rossem MC, den Butter PCP, Allegaert K, Reiss IKM, Tramper-Stranders GA. Efficacy and safety of switching from intravenous to oral antibiotics (amoxicillin-clavulanic acid) versus a full course of intravenous antibiotics in neonates with probable bacterial infection (RAIN): a multicentre, randomised, open-label, non- inferiority trial. Lancet Child Adolesc Health. 2022 Nov;6(11):799-809. doi: 10.1016/S2352-4642(22)00245-0. Epub 2022 Sep 9. PMID: 36088952. 2: Alrabadi N, Albustami IS, Abuhayyeh HA, El-Muwalla KM, Alawneh RJ, Al-Eitan LN, Alzoubi KH, Masadeh M, Khabour OF, Haddad R. Clavulanic Acid in the Scope of Helicobacter pylori Treatment: A Literature Review and Beyond. Curr Rev Clin Exp Pharmacol. 2021;16(2):128-138. doi: 10.2174/1574884715666200702121417. PMID: 32614751. 3: Song JY, Jensen SE, Lee KJ. Clavulanic acid biosynthesis and genetic manipulation for its overproduction. Appl Microbiol Biotechnol. 2010 Oct;88(3):659-69. doi: 10.1007/s00253-010-2801-2. Epub 2010 Aug 14. PMID: 20711575. 4: Saudagar PS, Survase SA, Singhal RS. Clavulanic acid: a review. Biotechnol Adv. 2008 Jul-Aug;26(4):335-51. doi: 10.1016/j.biotechadv.2008.03.002. Epub 2008 Mar 26. PMID: 18450406. 5: Daniel S, Doron M, Fishman B, Koren G, Lunenfeld E, Levy A. The safety of amoxicillin and clavulanic acid use during the first trimester of pregnancy. Br J Clin Pharmacol. 2019 Dec;85(12):2856-2863. doi: 10.1111/bcp.14118. Epub 2019 Dec 3. PMID: 31486528; PMCID: PMC6955403. 6: Vons C, Barry C, Maitre S, Pautrat K, Leconte M, Costaglioli B, Karoui M, Alves A, Dousset B, Valleur P, Falissard B, Franco D. Amoxicillin plus clavulanic acid versus appendicectomy for treatment of acute uncomplicated appendicitis: an open-label, non-inferiority, randomised controlled trial. Lancet. 2011 May 7;377(9777):1573-9. doi: 10.1016/S0140-6736(11)60410-8. PMID: 21550483. 7: Liras P, Rodríguez-García A. Clavulanic acid, a beta-lactamase inhibitor: biosynthesis and molecular genetics. Appl Microbiol Biotechnol. 2000 Oct;54(4):467-75. doi: 10.1007/s002530000420. PMID: 11092620. 8: Paradkar A. Clavulanic acid production by Streptomyces clavuligerus: biogenesis, regulation and strain improvement. J Antibiot (Tokyo). 2013 Jul;66(7):411-20. doi: 10.1038/ja.2013.26. Epub 2013 Apr 24. PMID: 23612724. 9: Keij FM, Tramper-Stranders GA, Koch BCP, Reiss IKM, Muller AE, Kornelisse RF, Allegaert K. Pharmacokinetics of Clavulanic Acid in the Pediatric Population: A Systematic Literature Review. Clin Pharmacokinet. 2022 May;61(5):637-653. doi: 10.1007/s40262-022-01116-3. Epub 2022 Mar 31. PMID: 35355215; PMCID: PMC9095526. 10: Jensen SE, Paradkar AS. Biosynthesis and molecular genetics of clavulanic acid. Antonie Van Leeuwenhoek. 1999 Jan-Feb;75(1-2):125-33. doi: 10.1023/a:1001755724055. PMID: 10422585. 11: Sánchez Navarro A. New formulations of amoxicillin/clavulanic acid: a pharmacokinetic and pharmacodynamic review. Clin Pharmacokinet. 2005;44(11):1097-115. doi: 10.2165/00003088-200544110-00001. PMID: 16231964. 12: Townsend CA. New reactions in clavulanic acid biosynthesis. Curr Opin Chem Biol. 2002 Oct;6(5):583-9. doi: 10.1016/s1367-5931(02)00392-7. PMID: 12413541. 13: Silveira AM, Gaspar Â, Benito-Garcia F, Couto S, Matias J, Chambel M, Morais-Almeida M. Anaphylaxis to Clavulanic Acid: A 7-Year Survey. J Investig Allergol Clin Immunol. 2019;29(4):311-313. doi: 10.18176/jiaci.0390. Epub 2019 Apr 8. PMID: 30957760. 14: Torres MJ, Montañez MI, Ariza A, Salas M, Fernandez TD, Barbero N, Mayorga C, Blanca M. The role of IgE recognition in allergic reactions to amoxicillin and clavulanic acid. Clin Exp Allergy. 2016 Feb;46(2):264-74. doi: 10.1111/cea.12689. PMID: 26662186. 15: Fawaz S, Dixon B, Barton S, Mohamed A, Nabhani-Gebara S. Suitability of Amoxicillin-Clavulanic Acid for Administration via Prolonged Infusion. Drug Des Devel Ther. 2020 Jan 10;14:103-109. doi: 10.2147/DDDT.S230459. PMID: 32021095; PMCID: PMC6959504. 16: Kurt-Kızıldoğan A, Çelik G, Ünsaldı E, Özcan S, Ayaz-Güner Ş, Özcengiz G. An integrative-omics analysis of an industrial clavulanic acid-overproducing Streptomyces clavuligerus. Appl Microbiol Biotechnol. 2022 Sep;106(18):6139-6156. doi: 10.1007/s00253-022-12098-4. Epub 2022 Aug 10. PMID: 35945361. 17: Sanna F, Melis MR, Angioni L, Argiolas A. Clavulanic acid induces penile erection and yawning in male rats: comparison with apomorphine. Pharmacol Biochem Behav. 2013 Feb;103(4):750-5. doi: 10.1016/j.pbb.2012.12.001. Epub 2012 Dec 9. PMID: 23234836. 18: Guo P, Chen Y, Yue C, Yu G. Simultaneous determination of clavulanic acid and tazobactam in bovine milk by HPLC. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2017 Apr;34(4):617-623. doi: 10.1080/19440049.2016.1277271. Epub 2017 Feb 3. PMID: 28156210. 19: Amaral L, Carneiro-Leão L, Cernadas JR. Acute Generalized Exanthematous Pustulosis Due to Clavulanic Acid. J Allergy Clin Immunol Pract. 2020 Mar;8(3):1083-1084. doi: 10.1016/j.jaip.2019.09.024. Epub 2019 Oct 17. PMID: 31631017. 20: Charoo NA, Rahman Z, Ali AA. Is the demonstration of bioequivalence for clavulanic acid required in amoxicillin-clavulanic acid orally administered immediate-release products? J Pharm Pharmacol. 2018 Jul;70(7):883-892. doi: 10.1111/jphp.12920. Epub 2018 Apr 6. PMID: 29633270.